Abstract
Introduction Immunosuppressants are drugs with narrow therapeutic indices and pharmacokinetic variation. Nonadherence to the therapy will cause over or underexposure leading to graft rejection.
Methods A cohort study was conducted on kidney transplant recipients from the nephrology clinic and therapeutic drug monitoring unit. Patients were asked to self-report their medication adherence using a self-assessment tool. Assessment by clinicians and variation of tacrolimus levels were evaluated. Tacrolimus concentration and kidney function were measured prospectively to correlate with patients’ adherence. The variation of tacrolimus levels between 20-43 % was classified as medium and above 43 % as poor adherence.
Results Among 58 participants, 33 (56.7%) were females. The maximum number of years attained after transplantation was 17, with a median duration of 5 years. On the self-reporting scale, 47.0% of adherence was due to fear of graft rejection. Among nonadherences, 77.4% had their immunosuppressive therapy two hours before or after the prescribed time. Based on the clinician score, 39 (67.2%) and 42 (72.4%) cases were identified as nonadherence and having tacrolimus C trough level above 20 % respectively. The median (95% CI) serum creatine and blood urea nitrogen levels in the medium category were 1.23 mg/dL (1.2-1.4) (P = 0.009) and 28.3 mg/dL (26.4-36.4) (P = 0.021) respectively. The corresponding values for poor adherence were 2.5 mg/dL (1.6-3.5) (P = 0.03) and 43.0 mg/dL (35.5-78.0) (P = 0.01).
Conclusions The fear of allograft rejection is linked to a better adherence rate. Nonadherent transplant recipients required close observation and frequent monitoring of immunosuppressant levels for graft survival.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by the Research Promotion Team, National research Council of Thailand (No.2563/820).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the Research Ethics Board of Health of Bhutan gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
e-mail: tobgayla2000{at}gmail.com
e-mail: kesaratmu{at}yahoo.com
Practitioners point Nonadherence to immunosuppressive drugs can lead to kidney rejection. Early detection of nonadherence and monitoring of drug levels will prolong graft survival.
The study title has been modified to fit the study design. The phrase structure was corrected in the Abstract to provide more meaning.
List of abbreviations
- IST
- Immunosuppressive therapy
- KTRs
- Kidney transplant recipients
- QoL
- Quality of life
- BAASIS
- Basel Assessment of Adherence to immunosuppressive medication scale
- TDM
- Therapeutic drug monitoring
- AUC
- Area Under the Concentration
- C trough
- Concentration trough level
- CV%
- Percentage covariate of variation
